| Bioactivity | GAD65 (206-220) is glutamic acid decarboxylase (GAD) 65-derived peptide, corresponding to residues 180-188. GAD65 is presented to T cells in association with I-Ag7 MHC class II molecules and a major pancreatic antigens targeted by self-reactive T cells in type I diabetes mellitus[1]. |
| Name | GAD65 (206-220) |
| CAS | 245124-26-9 |
| Shortening | TYEIAPVFVLLEYVT |
| Formula | C86H129N15O24 |
| Molar Mass | 1757.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Seon-Kyeong Kim, et al. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. Proc Natl Acad Sci U S A |
GAD65 (206-220)
CAS: 245124-26-9 F: C86H129N15O24 W: 1757.03
GAD65 (206-220) is glutamic acid decarboxylase (GAD) 65-derived peptide, corresponding to residues 180-188. GAD65 is pre
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.